Chinese police this weekend reportedly detained GlaxoSmithKline managers in Shanghai, Beijing, and Changsha.
The British pharma also known as GSK said authorities are investigating whether some of its senior execs in China have committed ‘economic crimes.’
The Wall Street Journal reported last month that a whistleblower claimed GlaxoSmithKline’s China staff have committed ‘widespread bribery of doctors to prescribe drugs.’
GSK disclosed in earlier SEC filings that the DOJ and SEC contacted the company in 2010 about possible violations of the FCPA in China and other countries.
China police over the weekend in the city of Changsha, Hunan Province, posted a notice that they are investigating senior managers at GSK China for economic crimes.